| Application no. and date | 09735906.1 (espacenet) (Federated) (European Patent Register), 20090424 | | Patent/reg. no. and date | DK/EP 2276485, 20140716 | | Publication date | 20110126 | | Priority no. and date | US 47729, 20080424 | | EP pub. no. and date |
EP 2276485 20110126 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 and Province Line Road
P.O. Box 4000
Princeton, NJ 08543-4000, US | | Applicant ref. no. | 14110-1 | | Inventor | ALBRIGHT, Charles, F., c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492, US,
BARTEN, Donna, Marie, c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492, US,
LEE, Francis, Y., c/o Bristol-Myers Squibb Company
Route 206 & Province Line Road
Princeton
New Jersey
08543, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/427 (2006.01) , A61P 25/00 (2006.01) , A61P 25/16 (2006.01) , A61P 25/28 (2006.01) , A61P 27/00 (2006.01) | | Title | ANVENDELSE AF EPOTHILON D I BEHANDLING AF TAU-ASSOCIEREDE SYGDOMME,
HERUNDER ALZHEIMERS SYGDOM | | Int. application no. | US2009041634 | | Int. publication no. | WO2009132253 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
